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Viruses Associated With Pneumonia in Adults
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Viral pneumonia, which is typically associated with disease in childhood, is increasingly recognized as
causing problems in adults. Certain viruses, such as influenza virus, can attack fully immunocompetent
adults, but many viruses take advantage of more-vulnerable patients. The latter include patients receiving
immunosuppressive therapy and elderly subjects, particularly those residing in long-term care facilities. The
range of viruses producing pneumonia in adults includes common agents, such as varicella-zoster virus and
influenza virus, as well as respiratory syncytial virus, human metapneumovirus, adenoviruses, picornaviruses,
and coronaviruses. The roles played by other agents, such as rhinoviruses and human bocaviruses, in pneu-
monia are still under study. While therapy for most of theses agents, at least in adults, has not yet been fully
clarified, it is reasonable to assume antivirals may work in certain situations if they are introduced early
enough in the course of infection.
It is estimated that 100 million cases of viral pneumo-
nia occur each year [1]. Recent reports suggest that the
etiology of many of these may now be identified [2–4]
using culture, serologic analysis, antigen identification,
or newer molecular techniques [2–5]; however, the at-
tribution of the pneumonia to viruses can be difficult
because viruses may be found in respiratory secretions
after aspiration from the upper airways or after asymp-
tomatic viral shedding. Further, coinfection with 2
organisms may occur. Research will have to clarify the
role of some of these agents, using techniques to de-
monstrate viral proliferation or viral components in
lung parenchyma. Determination of high viral loads in
respiratory specimens can be useful in this regard, but
few studies have reported viral loads, and these may
vary with the patients age, timing of the specimen,
and the type of specimen. Standards for viral loads
will need to be clarified. The following report sum-
marizes the viruses that have been associated with
pneumonia in adult patients.
INFLUENZA
Epidemics of influenza appear to have occurred from
ancient times, but literature about the disease dates
largely from the epidemic of 1918–1919, although in-
fluenza virus was not isolated until 1933 [6]. Louria
et al. [7] were perhaps the first to clarify the nature of
pneumonia during the influenza epidemic of 1957–
1958. They separated primary influenzal pneumonia
from bacterial pneumonia occurring in the wake of in-
fluenza and mixed viral-bacterial pneumonias. Louria
et al. identified 6 adult patients they felt had pneumo-
nia due to influenza virus on the basis of virus iso-
lation or serologic criteria and absence of significant
bacteriologic findings. Five of the 6 patients died.
During the same epidemic, Martin et al. [8] identified
32 fatal cases of influenza, 29 of which occurred in
patients aged ≥15 years. Eleven patients in this study
were classified as having influenza without bacterial
complications, including 4 with pneumonia or perihilar
congestion. Oseasohn et al. [9] reported 33 fatal cases
of Asian influenza, of which 9 were associated with
“sterile cultures” and at least 1 involved apparent pri-
mary influenzal pneumonia, and Kaye et al. [10] de-
scribed 3 cases attributed to influenza virus pneumonia.
Additional cases of influenzal pneumonia were repor-
ted following the epidemic of 1968. Lindsay et al. [11]
described 20 patients aged ≥15 years with pneumonia
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and influenza; 6 died, of whom 5 had typical histologic find-
ings of primary influenzal pneumonia. Burk et al. [12] repor-
ted 4 adult cases of pneumonia during that epidemic, one of
which appeared to have pneumonia due to the epidemic virus.
Noble et al. [13] reported a case of influenza pneumonia
documented by lung biopsy findings. The biopsy specimen from
this case was culture positive for influenza A virus, and all bac-
terial and fungal cultures of the biopsy specimen were negative,
suggesting that this was pneumonia attributable to influenza
virus. The biopsy contained evidence of necrotizing bronchitis
and bronchiolitis. The bronchial epithelium was eroded, and
alveoli contained prominent hyaline membranes, edema fluid,
and red blood cells, with mild interstitial inflammation.
Following episodic reports of pneumonia associated with
H5N1 avian influenza virus [14], a swine influenza pandemic
occurred in 2009 [15], during which the rate of hospitalization
reached 7% [16] and the rate of pneumonia was reported as
0.4% [16]. Publications detailed viral pneumonia associated with
the swine virus and allowed comparisons with seasonal influen-
za [16–20]. Common features of influenza were fever and cough
[15], and patients developing pneumonia often complained of
dyspnea. The interval between onset of symptoms and hos-
pitalization usually was 2–6 days. Overall, 28% of hospitalized
patients were admitted to intensive care units (ICUs) [21, 22],
and 12%–59% developed adult respiratory distress syn-
drome [23, 24]. Mortality due to viral pneumonia reported in
these studies ranged from 20% to 25%. Patients at risk for severe
outcomes from swine influenza in 2009 included those with
cardiac disease, pulmonary disease, or diabetes mellitus.
Frequent radiographic signs of influenzal pneumonia in-
cluded patchy bilateral lower lobe infiltrates or interstitial infil-
trates [25, 26]. Lactic dehydrogenase levels were often raised in
patients with influenzal pneumonia [26].
Pregnancy was associated with an increased risk of H1N1
pneumonia, and rates 4–9 times greater than those of the
general public were reported [21, 23]. Pneumonia occurred in all
trimesters, as well as in the postpartum period [24], but the in-
cidence was greatest in the third trimester [17]. Mortality in this
group was comparable to that in the general public [27, 28].
The pathology of primary influenzal pneumonia is charac-
terized by capillary thrombosis, focal necrosis of the alveolar
wall, development of hyaline membranes in alveoli, alveolar
edema, hemorrhage, necrotizing bronchitis, and bronchiolitis
(Figure 1) [29, 30]. Several studies have improved our under-
standing of this disease process. Higher viral loads have been
found in some patients with a fatal outcome from H5N1 influ-
enza. To et al. [31] have shown that the viral load was slower
to decline in cases of acute respiratory distress syndrome due
to H1N1 influenza virus and that interleukin 6, interleukin 10,
and interleukin 15 levels were elevated in the plasma of these
patients.
ADENOVIRUSES
Adenoviruses include >50 serotypes, but only about one-third
are associated with human disease. More than 80% of infec-
tions, including pneumonia, associated with these viruses
occur in children, especially those <4 years old, but they
account for 1%–7% of adult respiratory infections [32]. In
military recruitment centers [33, 34], febrile respiratory disease
is common, and cases of pneumonia have been reported [35].
Pneumonia cases in recruits were milder, were preceded by
upper respiratory tract symptoms, and included rales and
rhonchi on auscultation, leukocyte counts that were not ele-
vated, and infiltrates on chest radiographs that were patchy
and irregular or reticular. Resolution occurred in all 12 mili-
tary patients described by Bryant and Rhoads [35]. However,
Dudding et al. [36] reported fatal outcomes for 3 other trai-
nees with adenoviral pneumonia. Recent reports have included
adults who were immunosuppressed and experienced disas-
trous consequences from adenoviral pneumonia [37], but
reports of adenovirus pneumonia in immunocompetent adults
have also been published, as reviewed by Clark et al. [38].
These authors found 19 articles reporting on 21 immunocom-
petent patients with adenoviral pneumonia. The mean age of
these patients was 40 years, and fever (90%), cough (81%),
and dyspnea (71%) were frequent. The median leukocyte
count was 7.7 cells/mm3, but 52% of patients were lymphope-
nic. The most common radiograph finding was bilateral inter-
stitial markings. Pneumonia due to adenovirus has also been
reported in closed populations of adults [39].
Figure 1. Lung biopsy specimen from a patient with influenzal pneu-
monia, showing numerous necrotic cells in alveolar spaces, hyaline mem-
branes, destruction of bronchial walls by neutrophils, and intra-alveolar
hemorrhage, as well as occasional streptococcus pneumonia in alveolar
spaces (kindly provided by Dr Fritz Lin, UCI Department of Pathology).
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A strain of adenovirus first identified in Dutch military re-
cruits in 1955 has become a predominant circulating serotype.
Tate et al. [40] reported the occurrence of this serotype in a
US Air Force training facility. Twenty-three of 551 infected
trainees were hospitalized with pneumonia, and 1 died. Lewis
et al. [41] described an outbreak of adenovirus serotype 14
among civilians in Oregon with a median age of 51.9 years. Of
a total of 67 cases, 29 were hospitalized; 26 of the hospitalized
patients had abnormal chest radiograph findings, of whom
10 (38%) had infiltrates involving >1 lobe. Eighteen patients
required critical care, and 7 (18%) patients died. Similarly,
Esposito et al. [42] reported an outbreak of adenovirus sero-
type 14 infection on an island in southeast Alaska. Among 32
cases of pneumonia (median age, 47.5 years), they found 18
confirmed and 3 probable cases due to serotype 14. Pneumo-
nia in 10 patients progressed to severe disease, and 1 died.
CORONAVIRUSES
Coronaviruses may also produce pneumonia in adults. In
2003, the epidemic of severe acute respiratory syndrome
(SARS) [43–45] emerged. SARS coronavirus infection was first
detected in Guangdong province in China but spread to Hong
Kong, Vietnam, Singapore, and Canada. Patients presented
with fever, myalgias, malaise, chills, and cough [45]. Dyspnea
and pleuritic pain came later, sometimes with diarrhea. Lym-
phocytopenia was common. Other findings occasionally seen
included thrombocytopenia and increased levels of D-dimers
and liver enzymes. Between 60% and 100% of patients had
abnormal findings on initial chest radiographs, with ground-
glass opacities seen most commonly. Between 20% and 30% of
patients required admission to the ICU, with most needing
mechanical ventilation. The overall case-fatality rate approxi-
mated 10%, with a worse burden among patients aged >65
years (mortality, 50%). Children aged <12 years tolerated the
virus better.
Other coronaviruses have been shown to cause pneumonia
in adults. Woo et al. [46] found coronavirus HKU 1 in nasal
washings from 10 of 418 patients with pneumonia; 9 who
tested positive were adults. The median age of the 10 patients
was 71.5 years; 8 had underlying disease, and 2 died. The
disease was indistinguishable from community-acquired pneu-
monia due to other agents. Falsey et al. [47] evaluated 100
older adults hospitalized with cardiopulmonary illness and
found 8 patients infected with coronaviruses; 5 had corona-
virus 229E, and 3 had coronavirus OC 43. Two patients with
coronavirus infections had pneumonia. All patients had signi-
ficant underlying disease, but all recovered. Johnstone et al. [48]
reported that 4 of 193 adult patients admitted to the hospital
with community-acquired pneumonia were infected with coro-
navirus OC 43.
RESPIRATORY SYNCYTIAL VIRUS
Respiratory syncytial virus (RSV) is also significant cause of
pneumonia in adults. Dowell et al. [49], in a study of patients
admitted to the hospital for community-acquired pneumonia,
reported that RSV was the third most common cause of commu-
nity-acquired pneumonia in hospitalized patients, behind Strep-
tococcus pneumonia and influenza virus. Johnstone et al. [48]
reported that RSV was responsible for 2.6% of community ac-
quired-pneumonia cases in adults. Thompson et al. [50] esti-
mated that, between the 1990–1991 and 1998–1999 pneumonia
seasons, RSV was associated with 2707 deaths annually; 78% of
deaths related to respiratory/circulatory problems occurred in
people aged >65 years.
The clinical features of RSV infection in hospitalized patients
included nasal congestion, dyspnea, and wheezing. Cough was
nearly universal. Twenty percent of these patients had pneu-
monia. Dowell et al. [49] also noted that wheezing was more
frequent in RSV pneumonia patients than in patients with
pneumonia due to other causes, as was the presence of rhonchi
and nonelevated white cell counts. Radiographically, the infil-
trates associated with RSV pneumonia were often small, focal,
and unilateral, although Dowell et al. [49] had patients with
pneumonia with infiltrates reported to be lobar in distribution.
Falsey et al. [51] reported that the death rate for elderly hos-
pitalized patients with RSV infection was 10%; mortality spe-
cifically associated with pneumonia was not noted. Risk factors
for severe infection included underlying chronic pulmonary
disease and low serum neutralizing antibody levels [52] and,
for respiratory failure, included concurrent cardiopulmonary
disease and high nasal viral loads.
Outbreaks of RSV infection have occurred in long-term
care facilities, with high attack rates and high death rates [53].
RSV infection is a significant risk for bone marrow transplant
recipients and patients with leukemia, among whom mortality
rates have approximated 50%.
HUMAN METAPNEUMOVIRUS
Human metapneumovirus (HMPV) is closely related to RSV.
By the age of 25 years, everyone has been infected with this
agent, but during early life, infections result in incomplete im-
munity, allowing for recurrent infections.
In adults, Walsh et al. [54] sought HMPV in 1386 hospital-
ized patients. They found 91 patients infected with HMPV
alone and 27 dually infected with HMPV and a second agent.
Among 91 hospitalized patients, 23 developed pneumonia, 12
needed transfer to the ICU, 11 needed ventilator support, and
6 died. The average age of patients who died was 85 years.
Details about the pneumonia cases were not provided. John-
stone et al. [55] prospectively studied patients with pneumonia
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who were admitted to 5 Edmonton, Canada, hospitals. They
identified 193 patients with adequate nasopharyngeal samples
for testing, including 8 patients with pneumonia due to
HMPV. All 8 had comorbid cardiac or pulmonary disease,
and all had cough, but only 1 had fever. Most had dyspnea
with low oxygen saturations, all had normal white cell counts,
and all but 1 were lymphocytopenic. Fifty percent had pneu-
monia involving >1 lobe, and 3 had bilateral infiltrates. There
was no ICU admission in the group and no deaths. Hamelin
et al. [56] found that 6 of 145 patients who had chronic ob-
structive pulmonary disease and pneumonia and were ad-
mitted to the emergency department in Quebec, Canada, over
2 winter/spring seasons were infected with HMPV.
Like RSV, HMPV can also cause outbreaks in long-term care
facilities. Boivin et al. [57] reported that 96 of 364 residents of a
long-term care facility developed respiratory disease over a 6-
week period. There were 6 confirmed infections with HMPV in
the group, and 3 infected patients died with pneumonia. Real-
time polymerase chain reaction (PCR) of an autopsy specimen
from a 29-year-old female revealed HMPV in her bronchial epi-
thelium. Louie et al. [58] also described an outbreak in a long-
term care facility, where 26 of 171 residents were infected and 8
developed pneumonia, including 2 who were hospitalized and 1
who died. The mean age of these patients was 70 years. Honda
et al. [59] reported a similar outbreak from Japan.
HMPV has also been reported to cause pneumonia in im-
munocompromised patients [60, 61]. Like RSV, ribavirin has
in vitro activity against this virus [52].
OTHER AGENTS
Parainfluenza viruses also cause disease in children, but
occasional examples of these same viruses producing pneumo-
nia in both immunocompetent and immunoincompetent
adults have been reported. Wenzel et al. [62] described 3 US
Marine recruits with pneumonia and serological evidence of
parainfluenza virus type 1 infection and 2 US Marine recruits
with pneumonia and serological evidence of parainfluenza
virus type 3 infection. All of the recruits were febrile, and
2 had modest elevations in their white cell counts. Marx
et al. [63] described 1 patient with lobar pneumonia who had
serological changes compatible with infection with parain-
fluenza virus type 1 infection and no other organisms isolated.
An adult with pneumonia attributed to parainfluenza virus
type 3 was described by Cunha et al. [64]. The patient had
patchy interstitial infiltrates, was febrile, and had evidence of
leukocytosis and relative lymphopenia. Parainfluenza virus
type 3 pneumonia has also been reported in a patient who
underwent hematopoietic stem cell transplantation [65].
Gremillion and Crawford [66] reported on 106 US Air
Force recruits with measles virus pneumonia. This constituted
3.3% of 3220 measles cases seen over a 42-month period. The
illness in these patients was characterized by high fevers, long
hospital stays, and interstitial infiltrates, with pure viral infec-
tions. Bacterial superinfections in the lungs (in 30% of cases),
sinuses, and ears were common. Liver function abnormalities
were also common, but none of these patients died. Measles
virus pneumonia appears 3 times more frequently in pregnant
women with the disease [67] and, in immunocompromised
patients, may occur as giant cell pneumonia.
Enteroviruses, including coxsackieviruses and rhinoviruses,
have also been reported to be associated with pneumonia in
adults. Hayden [68] reviewed the evidence that rhinoviruses can
replicate in the lower respiratory tract. Hohenthal et al. [69],
in a study of 231 cases of community-acquired pneumonia,
found 5 cases where enteroviruses were the only agents found
and 2 where rhinoviruses were the only agents identified. Re-
cently, Legay et al. [70] reported on a 76-year-old male with a
fatal case of pneumonia in which coxsackievirus A 16 was
identified by PCR from bronchoalveolar lavage fluid, serum,
and pharyngeal secretions. There was an associated 8-fold rise
in antibody titer. Ghosh [71] described 4 adult patients who
had significant myelosuppression following blood and marrow
transplantation and also developed rhinovirus infection and
fatal pneumonia. No other pathogens, save rhinoviruses, were
isolated from these 4 individuals, and interstitial pneumonitis
was found at autopsy.
Human bocaviruses are novel parvoviruses isolated from
2%–19% of samples taken from patients, especially children,
with acute respiratory disease [72] and has also been found in
blood. Primary human bocavirus infection can be followed by
a long period of viral shedding frequently associated with
other agents. Its exact role in producing respiratory disease is
under investigation. Fry et al. [73] studied 1171 patients in
Thailand who had signs and symptoms of pneumonia under-
went chest radiography. Four of these patients with pneumo-
nia were aged ≥65 years and had human bocavirus infection,
including 2 from whom these were the only agents detected.
Varicella-zoster virus is known to produce pneumonia,
especially in adults. In a review by Triebwasser et al. [74],
pneumonia was reported to occur in 14% of adults with vari-
cella-zoster virus infections who were serving in the US Air
Force. The most frequent radiographic finding in adults with
chicken pox–associated pneumonia was a nodular infiltrate,
often with peribronchial distribution. Hypoxemia was common.
White cell counts were usually normal, and most patients
were febrile. The mortality rate for chicken pox–associated
pneumonia in adults before effective chemotherapy was re-
ported to be 10%–30%.
Herpes simplex virus (HSV) is also known to cause pneumo-
nia, but chiefly in immunocompromised patients. Shah and
Chemaly [75] reviewed the occurrence of this disease in patients
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with hematologic malignancies, noting that many of the pneu-
monias attributable to this virus occurred in this setting. Most of
the patients they reviewed were infected with HSV type 1 and
experienced reactivation of the virus. Findings often involved
low-grade fever, cough, dyspnea, and wheezing. Hypoxia was
common, sometimes requiring the use of ventilators. Radio-
graphic findings were nonspecific, but ground-glass-appearing
lesions were commonly seen on computed tomographic scans of
the lungs in this group. Ramsey et al. [76] also reported on 17
adult patients (age, ≥17 years) with hematologic problems, all
but one of whom underwent bone marrow transplantation. All
transplant recipients had pneumonia, all 17 patients had post-
mortem lung cultures that were positive for HSV, and 15
patients had histologic evidence of HSV in the lungs. Other in-
fections occurred concomitantly in all but 4 of the patients.
Cytomegalovirus is known to cause pneumonia in immu-
nosuppressed patients, especially bone marrow transplant
recipients [77], but because of the unique nature of the disease
and the constraints of space, this virus will not be reviewed
here. Epstein-Barr virus has been associated with pneumonia,
as reported by Siskandan et al. [78], who detected the virus in
lung tissue, using riboprobes. Hantavirus may cause a pneu-
monic picture [79] due largely to the presence of interstitial
edema, and recent reports have suggested that mimivirus and
parechoviruses may be associated with pneumonia in adults,
but confirmation of the role of these viruses in pulmonary
infections in adults awaits additional research.
Viruses play a part in adult pneumonia, but the exact role
some viruses play in these infections awaits additional studies
to determine whether they are innocent bystanders, organisms
predisposing individuals to subsequent infections, or causative
microorganisms.
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